Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q1 2025 Earnings

10MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.48

-0.45

-0.41

-0.37

Details

Expected EPS

-0.463333

Actual EPS

-0.37

Surprise EPS

0.09

Surprise Percent

+20.14%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.37 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.